Lupin stock gains on stronger profits and steady valuations

Published on 09/18/2026 at 12:27 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Lupin stock traded near INR 2,085 on September 18, 2026, holding close to recent highs and reflecting robust earnings momentum. The company’s latest quarterly figures show sharply higher profit and improving margins compared with the prior year.

Lupin, INE326A01037, Illustration mit AI erstellt.

Lupin stock (ISIN INE326A01037) traded around INR 2,085 on the National Stock Exchange of India as of September 18, 2026, leaving the pharmaceutical group valued firmly in the large-cap bracket and supported by stronger recent earnings.

Earnings growth underpins Lupin stock

According to Sahi Markets, Lupin reported consolidated net profit of INR 1,415 crore in its latest available quarter, Q1 of the current fiscal year, marking a year-on-year increase from a lower profit level in the prior-year quarter and indicating a clear improvement in earnings momentum.

In the same Q1 reporting period, Lupin’s revenue base grew at a double-digit rate compared with the previous year, and management highlighted margin expansion driven by a more favorable product mix and efficiency measures, as summarized in the company’s investor information on Lupin’s investor-relations portal.

Profit comparison and margin dynamics

Based on the Q1 figures reported by Sahi Markets, the INR 1,415 crore consolidated net profit in the current Q1 stood significantly higher than the profit reported in the same quarter a year earlier, underscoring a notable year-on-year improvement in Lupin’s profitability and supporting the present valuation level of Lupin stock.

The Q1 margin trend, as outlined in Lupin’s communications via its investor-relations pages on Lupin, showed operating and net margins widening compared with the previous fiscal year’s Q1, giving investors greater confidence that earnings growth is underpinned by structural improvements rather than only short-term factors.

Stock level and market perspective

With Lupin stock trading near INR 2,085 on the NSE on September 18, 2026, the current price sits relatively close to recent highs observed in the Indian market, reflecting the company’s improved earnings profile and the broader supportive backdrop for large-cap Indian pharmaceuticals.